Cybin Announces Successful Completion of In Vivo Preclinical Studies for its Deuterated Psilocybin Analog CYB003 Supporting Advancement into Phase 1/2a Clinical Trial
Marijuana Stocks, Finance, & InvestingUncategorized March 30, 2022
After strong preclinical testing results, Cybin is looking to advance CYB003 into a Plase 1/2a clinical trial, estimated for mid-2022.
Read moreThe 420 Hotels Obtains Provisional License, Paving the Way for Denver’s First Hotel With a Legally Licensed Lounge for Cannabis Consumption
Marijuana Industry News March 30, 2022
Bermuda House of Assembly Approves Legislation to Legalize Cannabis
Marijuana Industry News March 30, 2022
Vermont Receives More Than 400 Prequalification Applications from Cannabis Businesses
Marijuana Industry News March 30, 2022
Equity Compensation for Cannabis Employees
Uncategorized March 30, 2022
Previously we wrote about equity compensation for cannabis employees from the perspective of companies. We have been dealing with more and more companies adding equity to their overall compensation scheme, so now is a good time to revisit it from the employee perspective. For an overview of the types of equity compensation available, see here.
The post Equity Compensation for Cannabis Employees appeared first on Harris Bricken Sliwoski LLP.
Read moreBright Green Announces Filing of Registration Statement for Proposed Direct Listing of its Class A Common Stock
March 29, 2022